What's Going On? - Staar Surgical
Aug 7, 2024 · STAAR Surgical Strengthens Leadership Team with Appointments of Nancy Sabin as Chief Marketing Officer and Nathaniel Sisitsky as General Counsel Press release 04.29.2024
STAAR Surgical Company - Press Releases
Dec 31, 2024 · Transfer Agent. Equiniti Trust Company LLC. PO Box 500 Newark, NJ 07101 (800) 937-5449. Transfer Forms and Help
Homepage - Staar Surgical
STAAR designs, develops, manufactures and markets implantable lenses for the eye with companion delivery systems. These lenses are intended to provide visual freedom for patients, lessening or eliminating the reliance on glasses or contact lenses.
Patrick F. Williams Appointed Chief Financial Officer of STAAR …
Jul 6, 2020 · LAKE FOREST, Calif.--(BUSINESS WIRE)-- STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems for the eye, today announced that Patrick F. Williams has joined the Company as Chief Financial Officer effective today.
STAAR Surgical Company - STAAR Surgical Celebrates Three …
Dec 31, 2024 · LAKE FOREST, Calif.--(BUSINESS WIRE)-- STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of the EVO family of Implantable Collamer ® Lenses (EVO ICL) for myopia, astigmatism and presbyopia, comes to the American Society of Cataract and Refractive Surgery Annual Meeting (ASCRS) in Boston from April 5-8, 2024 ...
What's Going On? - Staar Surgical
Nov 15, 2023 · STAAR Surgical Announces Preliminary Results for Fourth Quarter and Fiscal 2023 Press release
STAAR Surgical Company - STAAR Surgical Announces U.S. FDA …
Dec 31, 2024 · LAKE FOREST, Calif.--(BUSINESS WIRE)-- STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems for the eye, today announced that the U.S. Food and Drug Administration (FDA) has granted approval of the EVO/EVO+ Visian® Implantable Collamer® Lens (“EVO”) for ...
STAAR Surgical Reports First Quarter 2024 Results
May 7, 2024 · LAKE FOREST, Calif.--(BUSINESS WIRE)-- STAAR Surgical Company (NASDAQ: K), a leading developer, manufacturer and marketer of the EVO family of Implantable Collamer® Lenses (EVO ICL™) for myopia, astigmatism and presbyopia, today reported financial results for the first quarter ended March 29, 2024.
Our Mission - Staar Surgical
STAAR designs, develops, manufactures and markets implantable lenses for the eye and companion delivery systems. These lenses are intended to provide visual freedom to patients, lessening or eliminating the reliance on glasses or contact lenses.
STAAR Surgical Announces Strategic Alliance Agreement with …
Dec 17, 2019 · LAKE FOREST, Calif.--(BUSINESS WIRE)-- STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems for the eye, today announced it has entered into a strategic alliance with the California Center for Refractive Surgery (CCRS), a …